Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 11, 2017
Patent Application Number
12081123
Date Filed
April 10, 2008
Patent Citations Received
Patent Primary Examiner
Patent abstract
This invention relates to methods of treating and ameliorating congenital and neonatal hyperinsulinism and post-prandial hypoglycemia, comprising the step of administering an antagonist of the Glucagon-Like Peptide-1 (GLP-1) receptor, e.g. a GLP-1 fragment or analog thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
